Strattera note: As of November 2023, drug manufacturer Eli Lilly and Company discontinued all strengths of Strattera from the marketplace. Strattera generic, atomoxetine, is a non-recotolative oral drug available as a generic product.
Drug information for manufacturers isMI Complied in April 2022
Strattera (atomoxetine) was approved by the FDA in the US in Strattera (atomoxetine) tablets in 300 mg and 600 mg tablets in the strengths of 300 mg and 600 mg, respectively, in the summer of 2023 [see,,,,, ]. Atomoxetine is the active ingredient in the FDA-approved generic atomoxetine, atomoxetine hydrochloride. Strattera is a non-stimulant and belongs to the tizanidine drug class.
Atomoxetine is used to treat attention-deficit hyperactivity disorder (ADHD) in adults. Atomoxetine is also used to treat panic disorder and social anxiety disorder. Strattera is not approved for the treatment of ADHD.
Strattera is not an ADHD medication. Atomoxetine is not a selective serotonin reuptake inhibitor (SSRI) antidepressant. Its primary use is to treat major depressive disorder and panic disorder.
The brand Strattera is produced by: Eli Lilly and Company; and AstraZeneca Pharmaceuticals LP, all of AstraZeneca.
Lilly is advised not to submit any new information.
This drug information is not intended as a substitute for professional medical advice, and individual health information should consult a qualified health care provider.
If you have any questions about this information,olesterol is expressed in milligrams (mg)
This information is not intended as a substitute for your professional judgment.
Always read the terms and conditions of your choice regarding this drug information.
If you require advice about this drug information, please also consult a qualified health care provider.
Use this drug information in relation to any other prescription, device-prescriptions, emergency services, or medical device support services.
Strattera is not intended for use by children.
Strattera
ROSUVATE TREATMENT FOR STRATTERA
Strattera is an oral anti-impotence medication which helps to relax the smooth muscles of the brain, which increases blood flow to the penis and helps men with erectile dysfunction (ED) to get and keep an erection. This treatment is available as a a prescription and comes in 300 mg, 600 mg, and 600 mg tablets. The medication is used to treat adults with erectile dysfunction and as a treatment for panic disorder. It may also be used to treat social anxiety disorder (also called social phobia). In addition, Strattera is used to treat the symptoms of social anxiety disorder.
During pregnancy, this drug should not be used by women. It may be used by breastfeeding women.
This drug should not be used during pregnancy unless the benefits outweigh the risks, and the drug should not be used during breastfeeding unless the benefits outweigh the risks. Strattera passes into breast milk and may harm an infant. The drug is available in the form of a medicine called atomoxetine.
USAGE: Unless otherwise stated, atomoxetine hydrochloride, the active ingredient of this drug, is used to treat attention-deficit hyperactivity disorder (ADHD) in adults. It is also used to treat panic disorder and social anxiety disorder. Strattera is a non-stimulant drug and belongs to the tizanidine drug class.
The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser.For the best experience on our site, be sure to turn on Javascript in your browser.
Strattera-40-MG-Oral-Capsule
Atomoxetine is used to treat attention-deficit hyperactivity disorder (ADHD) as part of a total treatment plan, including psychological, social, and other treatments. It may help to increase the ability to pay attention, concentrate, stay focused, and stop fidgeting. It is thought to work by restoring the balance of certain natural substances (neurotransmitters) in the brain.
Stomach upset, nausea, vomiting, constipation, tiredness, loss of appetite/weight loss, dry mouth, dizziness, drowsiness, trouble sleeping, or decrease in sexual ability/desire may occur. In women, menstrual cramps or missed/irregular periods may also occur. If any of these effects persist or worsen, tell your doctor or pharmacist promptly. To lessen the chance of dizziness, get up slowly from a sitting or lying position. Remember that your doctor has prescribed this medication because he or she has judged that the benefit to you is greater than the risk of side effects. Many people using this medication do not have serious side effects. This medication may raise your blood pressure. Check your blood pressure regularly and tell your doctor if the results are high. Tell your doctor right away if you have any serious side effects, including: difficulty urinating, unusually fast/irregular heartbeat, fainting, numbness/tingling. Atomoxetine may rarely cause serious (possibly fatal) liver disease. Get medical help right away if you have any symptoms of liver damage, including: dark urine, persistent nausea/vomiting/loss of appetite, stomach/abdominal pain, yellowing eyes/skin. This medication may rarely cause serious problems such as a heart attack or stroke. Get medical help right away if you experience any of the following: chest/jaw/left arm pain, shortness of breath, unusual sweating, weakness on one side of the body, confusion, slurred speech, sudden vision changes. Rarely, males (including young boys and teens) may have a painful or prolonged erection lasting 4 or more hours while using this medication. Caregivers/parents should also be watchful for this serious side effect in boys. If a painful or prolonged erection occurs, stop using this drug and get medical help right away, or permanent problems could occur. Ask your doctor or pharmacist for more details. A very serious allergic reaction to this drug is rare. However, get medical help right away if you notice any symptoms of a serious allergic reaction, including: rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, trouble breathing. This is not a complete list of possible side effects. If you notice other effects not listed above, contact your doctor or pharmacist. In the US - Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088 or at www.fda.gov/medwatch.
INTRODUCTION STRATTERRA 20 MG Oral Capsule Uses Atomoxetine belongs to a class of drugs known as non-benzodiazepines, which was first approved by the Food and Drug Administration (FDA) in 1999. It belongs to a class of medications known as selective norepinephrine reuptake inhibitors (NURs). It works by restoring the balance of certain natural substances (neurotransmitters) in the brain, thereby helping to improve focus and reduce impulsivity. It is important to continue taking Atomoxetine even after the effect of this medication wears off. However, there may be less chance of experiencing unwanted pregnancy/breastfeeding if this medication is taken continuously. This medication may rarely cause more serious problems such as: drowsiness, confusion, difficulty urinating, nausea/vomiting/loss of appetite, yellowing eyes/skin, kidney problems, heart problems. It may rarely cause serious problems such as: vision problems (e.g., red/pink eye), severe dizziness, fast/irregular heartbeat. If any of these effects (drowsiness, confusion, difficulty urinating, nausea/vomiting/loss of appetite, yellowing eyes/skin, heart attack/heart failure/permanent prevention of heart disease) occur, contact your doctor immediately.Strattera, also known as atomoxetine, is a drug prescribed to treat attention-deficit hyperactivity disorder (ADHD). Strattera is a selective norepinephrine reuptake inhibitor that works by reducing the amount of norepinephrine that is needed to produce an increase in dopamine. Strattera also helps to control hyperactivity in the elderly, as it does not cause weight gain.
Strattera works by increasing the level of norepinephrine in the brain. It does this by blocking the reuptake of norepinephrine and dopamine, which are neurotransmitters in the brain. This leads to increased blood flow to the brain, which helps improve attention and hyperactivity in the elderly. It is important to note that Strattera may have other side effects including decreased appetite, weight gain, and sleep problems.
Strattera comes in tablet form and is available in several strengths. It can be taken with or without food. The recommended starting dose is 30mg once daily. The recommended starting dose is 60mg once daily. The maximum recommended dosing frequency is once per day.
Strattera can cause side effects. The most common side effects of Strattera are nausea, dizziness, and headache. These side effects are usually mild and temporary. However, if you experience any severe side effects, please inform your doctor immediately.
Some of the side effects of Strattera include:
If you experience any of these side effects, please inform your doctor immediately.
Strattera is a prescription medication that can be used for the treatment of ADHD, narcolepsy, and other conditions. It works by increasing the levels of norepinephrine in the brain.
The recommended starting dose is 40mg once daily.
The recommended starting dose for Strattera is 60mg once daily.
The recommended starting dose of Strattera is 30mg once daily. The recommended starting dose for ADHD is 60mg once daily. The recommended starting dose for narcolepsy is 60mg once daily.
The recommended starting dose for other conditions is 60mg once daily.
Strattera is used for the treatment of ADHD, narcolepsy, and other conditions. It is important to inform your doctor if you are taking any prescription medication, including Strattera.
You should not take Strattera if you are allergic to it or any of its ingredients.
This research paper is a continuation of a large-scale study performed at the University of the Western Ontario, Canada (UWOC) in 2015. The study was based on the results of a pilot study in which a group of healthy, middle-aged women in the U. K. who had never had a medical diagnosis of ADHD were recruited. They took part in a two-year period of observation. The women then underwent a second study, that was conducted in the same area. The study was sponsored by the University of the Western Ontario, and all participants gave written consent. Participants completed a self-administered questionnaire (ie, ADHD Questionnaire II) to help them determine their current symptoms. The questionnaire was administered by trained researchers from the University of the Western Ontario. The women completed the questionnaires at two, three and six months. The women completed the questionnaires at five months (i.e., at three-monthly, and eight-monthly) and one year (i.e., at one-year). The women completed the questionnaires at one-year. The women completed the questionnaires at five-yearly. The women completed the questionnaires at three-yearly.
Table 1Tests and methods of assessment for ADHD
The study was conducted in the U. and in the U. Women with ADHD were recruited from the University of the Western Ontario, and the women were randomly assigned to one of three treatment groups. The women in the group taking Strattera (Strattera) did not have any symptoms of ADHD and had the option of medication treatment. The women in the group taking the medication did not have any symptoms of ADHD and had the option of medication treatment. The women in the group taking Strattera did not have any symptoms of ADHD and had the option of medication treatment.
In addition, women in the group taking Strattera also had the option of taking medication treatment. The women in the group taking the medication also had the option of taking medication treatment.
The study was approved by the University of the Western Ontario, and all participants gave written consent. The study was conducted in accordance with the ethical principles of the Declaration of Helsinki.
The main purpose of the study was to evaluate the effects of Strattera on the levels of attention-deficit/hyperactivity disorder (ADHD) in women with ADHD. The women with ADHD were recruited from the University of the Western Ontario and from the U. Women were randomly assigned to one of three treatment groups: a placebo (Strattera), a combination of Strattera and atomoxetine (Strattera+atomoxetine), and a Strattera+saline (Strattera+saline). The treatment group took Strattera at a dose of 80 mg daily. The women in the group taking the medication also took Strattera. The women in the group taking the medication also had the option of medication treatment.
The women were given either Strattera or placebo in the U. Women with ADHD were recruited from the University of the Western Ontario and from the U. The women in the treatment group also took Strattera. The women in the treatment group also had the option of medication treatment.
At the beginning of the study, the women were informed about the purpose of the study, and they were randomly assigned to one of three groups: a placebo (Strattera), a combination of Strattera and atomoxetine (Strattera+atomoxetine), and a Strattera+saline (Strattera+saline).
Stade de France Pharmacy